An injectable blood pressure drug has been recalled after the FDA has warned it could cause side effects, such as stroke or death.

More generally, markets have a way of recalibrating, and Venture Global’s IPO offers a nuanced lesson. It’s a reminder that valuations aren’t fixed by management or banker decree, but rather hammered ...